Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 1, 2014, Pages 55-62

  Hsu, Vivien M ^a   Chung, Lorinda ^b   Hummers, Laura K ^c   Wigley, Fredrick ^c   Simms, Robert ^d   Bolster, Marcy ^e   Silver, Rick ^e   Fischer, Aryeh ^f   Hinchcliff, Monique E ^g   Varga, John ^g   Goldberg, Avram Z ^h   Derk, Chris T ⁱ   Schiopu, Elena ^j   Khanna, Dinesh ^j   Shapiro, Lee S ^k   Domsic, Robyn T ^l   Medsger, Thomas ^l   Mayes, Maureen D ^m   Furst, Daniel ⁿ   Csuka, Mary E ^o   Molitor, Jerry A ^p   Alkassab, Firas ^q   Steen, Virginia D ^r   more..

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h Northwell Health   (United States)

ⁱ THOMAS JEFFERSON UNIVERSITY   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k ALBANY MEDICAL COLLEGE   (United States)

^l UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF TEXAS   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o MEDICAL COLLEGE OF WISCONSIN   (United States)

^p UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^q UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^r GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Pulmonary arterial hypertension; Registry; Scleroderma; Systemic

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE DURATION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HIGH RISK POPULATION; HUMAN; HYPOXIA; LONGITUDINAL STUDY; LUNG ARTERY PRESSURE; LUNG CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RISK FACTOR; SYSTEMIC SCLEROSIS; WALKING; AGED; COMPLICATION; HYPERTENSION, PULMONARY; MIDDLE AGED; RAYNAUD DISEASE; REGISTER; RISK;

ADULT; AGED; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RAYNAUD DISEASE; REGISTRIES; RISK; SCLERODERMA, SYSTEMIC;

EID: 84905255169     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.03.002     Document Type: Article

References (28)

1. Mukerjee D., George D., Coleiro B., et al. Prevalence and outcome in systemic sclerosis-associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003, 62:1088-1093.
2. Launay D., Sitbon O., Hachulla E., Mouthon L., Gressin V., Rottat L., et al. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era. Ann Rheum Dis 2013, 72:1940-1946. ([Epub Dec 2012-202489]).
3. Sabbagh M.R., Steen V.D., Zee B.C., Nalesnik M., Trostle D.C., Bedetti C.D., et al. Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J Rheumatol 1989, 16(8):1038-1042.
4. Komosci A., Vorobcsuk A., Faludi R., Pinter T., Lenkey Z., Kolto G., et al. The impact of cardio-pulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 2012, 51(6):1027-1036. [Epub Jan 5, 2012].
5. Denton C.P., Calies J.B., Phillips G.D., Wells A.U., Black C.M., Bois R.M. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997, 36:239-243.
6. Steen V.D., Graham G., Conte C., Owens G., Medsger T.A. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992, 35:765-770.
7. Steen V. Predictors of end-stage lung disease in systemic sclerosis. Ann Rheum Dis 2003, 62:97-99.
8. Hinchcliff M., Fischer A., Schiopu E., Steen V. Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 2011, 38:2172-2179.
9. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590.
10. LeRoy E.C., Black C., Fleischmajer R., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
11. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., Delcroix M., Denton C.P., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54(Suppl. 1):43-S54.
12. MacDonald S.L., Rubens M.B., Hansell D.M., Copley S.J., Desai S.R., DuBois R.M., et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001, 221:600-605.
13. Steen V., Medsger T.A. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997, 40:1984-1991.
14. Eakin E.G., Resnikoff P.M., Prewitt L.M., Ries A.L., Kaplan R.M. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998, 113:619-624.
15. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
16. Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007, 66:940-944.
17. Kawut S.M., Taichman D.B., Archer-Chicko C.L., et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003, 123:344-350.
18. Hsu V.M., Moreyra A.E., Wilson A.C., Shinnar M., Shindler D.M., Wilson J.E., et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of non-invasive tests with results of right heart catheterization. J Rheum 2008, 35:458-465.
19. Arcasoy S.M., Christie J.D., Ferrari V.A., Sutton M.S., Zisman D.A., Blumenthal N.P., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167:735-740.
20. Valerio C.J., Schreiber B.E., Handler C.E., Denton C.P., Coghlan J.G. Borderline mean pulmonary artery pressure in systemic sclerosis patients: trans-pulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 2013, 65:1074-1084.
21. Bae S., Saggar R., Bolster M., Chung L., Csuka M.E., Derk C., et al. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis 2012, 71:1335-1342.
22. Rosenkranz S. Pulmonary hypertension: current diagnosis and treatment. Clin Res Cardiol 2007, 96:527-541.
23. Steen V., Medsger T.A. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48:516-522.
24. Ciurzyński M., Bienias P., Lichodziejewska B., Kurnicka K., Szewczyk A., Glińska-Wielochowska M., et al. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis. Clin Rheumatol 2008, 27:991-997.
25. Yamamoto K., Burnett J.C., Jougasaki M., Nishimura R.A., Bailey K.R., Saito Y., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996, 28:988-994.
26. Chatterjee S. Pulmonary hypertension in systemic sclerosis. Semin Arthitis Rheum 2011, 41:19-37.
27. Stupi A.M., Steen V.D., Owens G.R., et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986, 29:515-524.
28. Shah A.M., Chung S.E., Wigley F.M., Wise R.A., Hummers L.K. Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients. Ann Rheum Dis 2013, 72:1136-1140.